title: Childhood intussusception in Uzbekistan: analysis of retrospective surveillance data.
abstract: BACKGROUND
  Estimates of baseline incidence of childhood intussusception could help safety monitoring after the introduction of rotavirus vaccines. We studied the incidence of intussusception in Uzbekistan, a GAVI-fund eligible state in Central Asia.
  
  
  METHODS
  We retrospectively reviewed intussusception cases in children <2 years of age treated during 2004-2008 at 15 hospitals in the Bukhara region of Uzbekistan. Demographic and clinical data as well as information on diagnostic and treatment practices were obtained from hospital records. We categorized cases using the Brighton collaboration clinical case definition and calculated the national incidence rate.
  
  
  RESULTS
  Over a 5-year study period, 67 confirmed cases were identified, of which 67% were boys. The median age was 12 months, and no seasonal trend in the distribution of cases was observed. The diagnostic methods used included abdominal radiography (87%) and ultrasonography (57%). Intussusception reduction by air enema was successful in 33 (49%) patients and 34 (50%) cases underwent surgery. A total of 4 deaths occurred, including 3 deaths in infants aged 0-6 months. The median length of hospital stay was 7.3 (range 0-37) days. The incidence of intussusception is estimated at 23 (95% CI 13.6-32.4) cases per 100,000 child-years, corresponding to approximately 237 cases annually.
  
  
  CONCLUSIONS
  This is the first study to estimate the incidence of childhood intussusception prior to the introduction of the rotavirus vaccination in Uzbekistan. A prospective surveillance system using a standardized case definition is needed in order to better examine the occurrence of intussusception in developing countries.
authors: Reference Laboratory, Tashkent, Uzbekistan. renatlatip@gmail.com
authors: Renat
authors: R
authors: Latipov
authors: Rajabboy
authors: R
authors: Khudoyorov
authors: Elmira
authors: E
authors: Flem
mesh_terms: D017677:Age Distribution; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D007443:Intussusception / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D011159:Population Surveillance; D011358:Product Surveillance, Postmarketing; D012189:Retrospective Studies; D022243:Rotavirus Vaccines / Q000009:adverse effects; D014610:Uzbekistan / Q000453:epidemiology
chemical_list: D022243:Rotavirus Vaccines